Gene And Cell Therapies In Asia: Indian Environment Evolving But Multiple Issues Unresolved

India has taken strides towards creating a supportive environment for its nascent gene therapy research, but the R&D and regulatory infrastructure is still evolving amid concerns over potential product costs.

Gene therapy
Gene And Cell Therapies Advance In Asia • Source: Shutterstock

India has seen an uptick in activity in gene therapy research over the past few years, with researchers more recently experimenting with the gene-editing tool CRISPR-Cas9, though for the most part things appear to be still evolving in the sector, amid lingering concerns around safety and ethical aspects.

Though the exact number of Indian institutes/firms currently engaged in gene therapy research is not easy to ascertain, previous studies and reviews have highlighted some like the Advanced Centre for Treatment, Research and Education for Cancer (ACTREC) in Mumbai, which is involved in gene therapy studies including in head and neck cancer using viral

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from India

More from Asia